Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progression

Abstract Introduction Current therapies for multiple sclerosis (MS) primarily reduce relapse rates and delay disability by targeting inflammation, while have limited efficacy against disease progression driven by neurodegenerative processes. We sought to identify and validate proteins for MS progres...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yuan Jiang, Jinyu Xiao, Ingrid Kockum, Pernilla Stridh, Qianwen Liu, Tomas Olsson, Lars Alfredsson, Xia Jiang
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2026-06-01
Serie:	Journal of Neuroinflammation
Soggetti:	Progressive multiple sclerosis Protein Drug targets Omics
Accesso online:	https://doi.org/10.1186/s12974-026-03895-z
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!